She pointed out that only 700 million doses were delivered through the COVAX programme instead of the promised 2 billion by the end of last year. Begum criticised the unequal distribution within the COVAX programme, noting that facilities can implement export bans to prevent wider vaccine distribution.

She thanked the hon. Member for North East Fife for initiating this debate, praising the roll-out of vaccines in the UK but highlighting stark inequality in access to vaccines globally. She pointed out that despite vaccine makers having produced enough doses to vaccinate the world several times over, vaccination rates remain dangerously low with only 8% of people in poorer countries vaccinated compared to 77% in richer countries.

She agreed with the hon. Member for North East Fife's opening remarks, stressing the need for a global response to tackle the pandemic. She noted that while richer countries have vaccinated 77% of their population, poorer ones have only managed 8%. Florence also raised concerns about HIV and the impact of the UK Government's cut in funding to UNAIDS by 83%, urging the Minister to speak with her colleagues in the Treasury to reverse this cut.

As chair of the British group of the Inter-Parliamentary Union, reports that a motion was unanimously agreed upon calling for parliamentarians to work with national Governments to eliminate all export restrictions and other trade barriers on covid-19 vaccines and their inputs. Emphasises the importance of extensive immunisation as a global public good.

Ian Causley supports efforts to increase transparency in global vaccine supply chains, suggesting that better information sharing could help address logistical bottlenecks and improve distribution efficiency. He also calls for increased financial support from wealthy nations.

Mr McDonnell criticised the UK for voting against a TRIPS waiver that would allow more affordable vaccine production, stating three-quarters of health workers in Africa remain unvaccinated and less than 5% of people in low-income countries have been fully vaccinated. He called for pharmaceutical companies to share their technology with WHO pools.

While noting that the UK has done well domestically, Karl McCartney highlights that global vaccine distribution remains a significant challenge. He emphasises the need for clearer and more effective international strategies to ensure equitable access worldwide.

The failure of Governments to support the Agreement on Trade-Related Aspects of Intellectual Property Rights waiver, proposed by India and South Africa, has led to a pernicious spread of coronavirus and high global death toll. No one is safe until everyone has access to vaccinations. The UK's opposition to the waiver continues to put hundreds of thousands of lives at risk. Will the Minister give way?

He criticised the UK Government for its decision to cancel the contract with Scottish vaccine company Valneva, highlighting the safety and efficacy of their vaccine. He pointed out that the Valneva vaccine is an inactivated whole virus candidate which could help close the vaccination gap and meet global humanitarian responsibilities by supplying vaccines to COVAX.

Paid tribute to the hon. Member for North East Fife, highlighted the inadequate vaccine access in low-income countries compared to high-income nations. Criticised COVAX's dependency on donated doses and under-delivery of vaccines. Emphasised the need for increased donations from wealthy countries like the UK, including support for syringes and needles. Called for global production increase through TRIPS waiver acceptance, data sharing, and technology transfer. Advocated for routine vaccination maintenance and funding for GAVI and Coalition for Epidemic Preparedness Innovations.

The MP highlighted the moral and economic imperative of achieving global vaccine equity, noting a significant disparity between vaccination rates in wealthy nations and poorer areas. She criticised the UK government's record on donations to low and middle-income countries compared to other nations. The MP also pointed out failures in managing surplus vaccines and urged for more transparent timelines for vaccine deliveries. Concerning costs, she asked the Minister about procurement prices per dose and how donated doses are accounted for against ODA targets.

Mr Burgon apologised for having to leave early and expressed concern over the failure of world leaders to deliver vaccines globally, highlighting that at least 5 million people have died from covid-19 and The Economist estimates a true excess death figure of almost 20 million. He criticized the government's prioritisation of pharmaceutical company profits over public health in low-income countries, noting less than 6% full vaccination rates there. Mr Burgon also pointed out that South Africa and India led calls for a temporary vaccine waiver but were opposed by the UK and Germany, leading to an international outcry against blocking the sharing of vaccine patents.

Ms Ali expressed gratitude towards the NHS but highlighted the failure of many governments, including the UK's, to meet vaccination targets. She noted that only 2% of global vaccine doses have been administered in Africa and emphasised the importance of international cooperation to prevent new variants from taking hold.

I am concerned about the disparity in global vaccine distribution, highlighting that over 80% of vaccines have been administered in wealthy nations while less than 2% are available in low-income countries. I urge the government to commit more resources to COVAX and work with international partners to address this urgent inequality. He thanked healthcare workers and NHS staff for the successful vaccine roll-out in Britain, highlighting that over 2.5 million vaccines were administered in the West Midlands alone. He praised the Government's financial support for GAVI and COVAX, noting Britain's pledge of £1.65 billion from 2020 to 2025 and its role in securing $8.8 billion at the GAVI replenishment conference. Clarke also discussed the success of polio vaccination programmes and visited Kenya where he saw the positive impact of COVAX vaccines.

He praised the availability of new vaccines in the UK but expressed shame over the slow response to vaccine needs in other countries. He highlighted the need for investment in vaccines and stressed the importance of sharing knowledge from research and development to spread health globally.